Clinical evolution of porphyria cutanea tarda (PCT) in HCV monoinfected and HIV/HCV co-infected patients after viral eradication with direct acting agents (DAA)- P. Rodriguez Cortes

International Workshop on HIV & Hepatitis Co-infection 2017

O_3: Pharmacokinetics of darunavir/cobicistat and etravirine alone and coadministered in HIV-infected patients- José Moltó, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Anxiety and depression in young people with perinatal HIV and their HIV negative siblings - Marthe Le Prevost

International Workshop on HIV & Pediatrics 2015

Oral Abstract Presentation #5 | Basma Abdi

European Meeting on HIV & Hepatitis 2024

Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Recreational Drugs are Associated with Viral Load Blips and Lower Adherence in a Prospective Cohort of Thai People with Acute HIV Infection - Camilla Muccini

APACC 2022

Update on changes in Hepatitis B and C in CEE countries- Miłosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

How does the reservoir influence the clinician's decisions- Carlo Federico Perno, MD, PhD

European Meeting on HIV & Hepatitis 2019

Immunotherapy of prostate cancer and urothelial cancer. Future directions | Winald Gerritsen, MD, PhD

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD

HIV DART and Emerging Viruses 2016